|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Cost of revenues (including related parties amounts of RMB 3,623, RMB 1,981 and RMB 2,161 for the years ended December 31, 2023, 2024 and 2025, respectively) | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling and marketing expenses | |||||
| General and administrative expenses | |||||
| Other operating income | |||||
| Research and development expenses | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Interest income | |||||
| Investment income | |||||
| Share of gains (losses) of equity method investments | |||||
| Impairment loss of long-term investments | |||||
| Gains (losses) from disposal of subsidiaries, net | |||||
| Foreign currency exchange gains (losses), net | |||||
| Loss before income taxes | |||||
| Income tax benefit | |||||
| Net loss | |||||
| Net income (loss) attributable to non-controlling interests | |||||
| Net loss attributable to Cloopen Group Holding Limited | |||||
| Net loss attributable to ordinary shareholders | |||||
| Other comprehensive income (loss): | |||||
| Foreign currency translation adjustment, net of nil income taxes | |||||
| Total other comprehensive income (loss) | |||||
| Comprehensive loss | |||||
| Comprehensive income (loss) attributable to non-controlling interests | |||||
| Comprehensive loss attributable to Cloopen Group Holding Limited | |||||
| Net loss per ordinary share | |||||
| Basic | |||||
| Diluted | |||||
| Weighted average number of ordinary shares outstanding used in computing net loss per ordinary share | |||||
| Basic | |||||
| Diluted | |||||
Loading...